GilteRInf 2022 Study (Gilteritinib Related Infections)

Clinical trial NCT05791890 · UNKNOWN

Trial details

NCT number: NCT05791890
Sponsor: University of Rome Tor Vergata
Status: UNKNOWN
Study type: OBSERVATIONAL

Acute Myeloid Leukemia

Start date: 2022-05-31
Primary completion: 2024-05-31
Enrollment: 78

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.